Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

The most interesting part of the ASCO poster to me is that 205% increase in p21 expression. Dose-dependent p21 expression and Kevetrin has the potential to increase p21 by that much! About a year ago I was trying to figure out if a 10% increase was note worthy it may or may not be but 205, yeah that has to be good. Can't wait to see p21 expression in cohort 10.

In the coming weeks we could have more disappearing lesions and tumors. I was growing impatient with Kevetrin phase 1 now I am rooting for Kevetrin 1500 and another 3 months of dose escalation.

In reflection, the only thing that didn't go great in this trial is the dose escalation particularly early on. Not sure if the CTIX should have pushed harder earlier on especially with the erythema issue but water under the bridge and they followed the standard protocol. We are just now starting to see what Kevetrin can do!

Oh yeah throw in B-ABX, B-OM, Prurisol and all the rest of the pipeline I have never been more excited to be invested here. I suspect we will be uplisted here in the next few weeks. My biggest hope with uplisting is just simply more volume so that a new somewhat fairly valued pps can be vetted.